Colfosceril palmitate, cetyl alcohol, tyloxapol | |
---|---|
Trade Name | Exosurf |
Orphan Indication | Adult respiratory distress syndrome |
USA Market Approval | USA |
USA Designation Date | 1993-01-11 00:00:00 |
Sponsor | GlaxoSmithKline;5 Moore Drive, P.O. Box 13398;Research Triangle Park, North Carolina, 27709 |